Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

had a baseline vastus lateralis muscle fat fraction (VL MFF) assessed by MRS in the range ≤5% or >30%, i.e. included in"off-target" group,

never been randomized because, the enrollment in the off target group was completed.

Aged ≥6 years old;

Are able to give informed assent and/or consent in writing signed by the subject and/or parent/legal guardian (according to localregulations);